study of ribociclib and pdr001 in hr metastatic breast cancer
Published 5 years ago • 3.5K plays • Length 7:23Download video MP4
Download video MP3
Similar videos
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
4:59
study of saci-io for hormone receptor positive metastatic breast cancer
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
23:00
what's new in metastatic breast cancer research | dana-farber cancer institute
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
1:24
encouraging findings with ribociclib in hr breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
8:09
what is metastatic breast cancer? | dana-farber cancer institute
-
7:43
study of abemaciclib for patients with rb-positive, triple negative metastatic breast cancer
-
39:15
metastatic breast cancer forum 2018: clinical trials 101 | dana-farber cancer institute
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
2:33
breast cancer: young mother embraces life | dana-farber cancer institute
-
1:41
dana-farber cancer institute | ian krop, md, phd, at sabcs 2020
-
3:45
new treatments for metastatic breast cancer
-
21:37
inflammatory breast cancer patient forum 2019, ibc genetics | dana-farber cancer institute
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
2:43
study of ds-8201a in her2-low, unresectable and/or metastatic breast cancer
-
1:06
asco22: breast cancer research by sara tolaney, md | dana-farber cancer institute